Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-22-021570
Filing Date
2022-12-14
Accepted
2022-12-14 16:34:08
Documents
2
Period of Report
2022-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3185
2 POWER OF ATTORNEY poa_beaupre.htm EX-24.1 8471
  Complete submission text file 0001567619-22-021570.txt   13132
Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVE. SUNNYVALE CA 94085
Business Address
Beaupre Darrin (Reporting) CIK: 0001581198 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38915 | Film No.: 221462593

Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Issuer) CIK: 0001676725 (see all company filings)

EIN.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations